NGNE · Neurogene Inc. · Documents
Market Cap
$710.00M
Shares
20.01M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-07-02 | 2026-06-30 | |
| 8-K | 2026-06-29 | — | |
| 8-K | 2026-06-08 | — | |
| 8-K | 2026-06-04 | 2026-06-03 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| 8-K | 2026-04-20 | — | |
| DEF 14A | 2026-04-16 | 2026-06-03 | |
| 8-K | 2026-03-24 | — | |
| 10-K | 2026-03-24 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-01-12 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-13 | — | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-09 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-08-11 | — | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-06-12 | — | |
| 8-K | 2025-06-09 | — | |
| 8-K | 2025-05-09 | — | |
| 10-Q | 2025-05-09 | 2025-03-31 | |
| DEF 14A | 2025-04-25 | — | |
| 8-K | 2025-04-14 | — | |
| 10-K | 2025-03-24 | 2024-12-31 | |
| 8-K | 2025-03-24 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-21 | 2024-11-20 | |
| 8-K | 2024-11-18 | — | |
| 8-K | 2024-11-18 | — | |
| 10-Q | 2024-11-18 | 2024-09-30 | |
| 8-K | 2024-11-12 | 2024-11-11 | |
| 8-K | 2024-11-04 | — | |
| 10-Q | 2024-08-09 | 2024-06-30 | |
| 8-K | 2024-08-09 | — | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-06-21 | — | |
| 8-K | 2024-06-18 | — | |
| 8-K | 2024-06-17 | 2024-06-14 | |
| 8-K | 2024-06-03 | — | |
| 10-Q | 2024-05-10 | 2024-03-31 | |
| 8-K | 2024-05-10 | — | |
| 8-K | 2024-05-07 | — | |
| DEF 14A | 2024-04-26 | — | |
| 8-K | 2024-04-25 | 2024-04-19 | |
| 8-K | 2024-04-22 | — |
Showing 1–50 of 123 filings
Key facts
CIK
1404644
CUSIP
64135M105
13F (30d)
65 filings
65 filers
Visit website
Investor relations